1. Home
  2. BAOS vs HCWB Comparison

BAOS vs HCWB Comparison

Compare BAOS & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baosheng Media Group Holdings

BAOS

Baosheng Media Group Holdings

HOLD

Current Price

$3.01

Market Cap

3.6M

ML Signal

HOLD

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$1.22

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAOS
HCWB
Founded
2018
2018
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
3.8M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
BAOS
HCWB
Price
$3.01
$1.22
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$35.00
AVG Volume (30 Days)
28.7K
79.4K
Earning Date
05-08-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$860,951.00
$422,026.00
Revenue This Year
N/A
$178.64
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.20
N/A
52 Week Low
$1.52
$0.95
52 Week High
$8.30
$41.20

Technical Indicators

Market Signals
Indicator
BAOS
HCWB
Relative Strength Index (RSI) 56.41 39.46
Support Level $2.78 $1.25
Resistance Level $3.52 $1.65
Average True Range (ATR) 0.25 0.14
MACD 0.04 0.06
Stochastic Oscillator 56.04 25.45

Price Performance

Historical Comparison
BAOS
HCWB

About BAOS Baosheng Media Group Holdings

Baosheng Media Group Holdings Ltd operates as a V-log streaming marketing service provider. The firm offers comprehensive marketing solutions. Its services are Internet effect marketing, V-log or short video streaming marketing including content production and operation, e-commerce marketing, original data platform system service, and AI technology. It provides one-stop and full-link deep customized marketing solutions for partners. Baosheng Group is also a core agency of domestic Internet companies such as Tencent, Alibaba, Bytedance, and Kuaishou, with performing channel marketing services, technologies, and applications.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

Share on Social Networks: